Stock listing
NASDAQ:BSEM BioStem Technologies, Inc. Stock
Follow BioStem Technologies, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BSEM
$0.635 USD -0.073 (-10.3%)
Close on Nov 20, 2026
- Day range
- $0.535 – $0.710 USDNov 20, 2026
- Volume
- 254,190 sharesNov 20, 2026
- Market cap
- $12.18M USDAt the close on Nov 20, 2026 · price × 19.18M shares outstanding
- 52-week range
- $0.535 – $8.400 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $457,085 USDMedian day 144,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BSEM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.635 | -0.073 | -10.3% | $0.700 | $0.710 | $0.535 | 254,190 | |
| $0.708 | -0.110 | -13.4% | $0.936 | $0.940 | $0.700 | 323,500 | |
| $0.818 | -0.117 | -12.5% | $0.951 | $0.952 | $0.810 | 187,100 | |
| $0.935 | -0.025 | -2.6% | $0.970 | $1.000 | $0.894 | 241,500 | |
| $0.960 | -0.090 | -8.6% | $1.200 | $1.240 | $0.960 | 225,900 | |
| $1.050 | -0.250 | -19.2% | $1.215 | $1.250 | $0.900 | 450,300 | |
| $1.300 | -0.170 | -11.6% | $1.435 | $1.599 | $1.280 | 400,800 | |
| $1.470 | +0.430 | +41.3% | $1.020 | $1.530 | $1.020 | 1,132,300 | |
| $1.040 | -0.080 | -7.1% | $1.080 | $1.290 | $1.000 | 445,100 | |
| $1.120 | -0.010 | -0.9% | $1.120 | $1.280 | $1.060 | 179,900 | |
| $1.130 | +0.090 | +8.7% | $1.030 | $1.150 | $1.010 | 100,800 | |
| $1.040 | -0.110 | -9.6% | $1.170 | $1.170 | $1.010 | 197,100 | |
| $1.150 | 0.000 | 0.0% | $1.180 | $1.200 | $1.120 | 195,400 | |
| $1.150 | -0.010 | -0.9% | $1.210 | $1.270 | $1.040 | 297,000 | |
| $1.160 | +0.040 | +3.6% | $1.200 | $1.290 | $1.140 | 194,000 | |
| $1.120 | -0.170 | -13.2% | $1.290 | $1.290 | $1.110 | 145,400 | |
| $1.290 | -0.220 | -14.6% | $1.540 | $1.590 | $1.210 | 262,400 | |
| $1.510 | +0.030 | +2.0% | $1.606 | $1.620 | $1.450 | 327,700 | |
| $1.480 | -0.060 | -3.9% | $1.590 | $1.600 | $1.420 | 185,700 | |
| $1.540 | -0.030 | -1.9% | $1.570 | $1.610 | $1.400 | 169,500 | |
| $1.570 | -0.090 | -5.4% | $1.680 | $1.740 | $1.570 | 133,900 | |
| $1.660 | -0.020 | -1.2% | $1.640 | $1.700 | $1.600 | 49,600 | |
| $1.680 | +0.040 | +2.4% | $1.620 | $1.780 | $1.550 | 197,200 | |
| $1.640 | +0.100 | +6.5% | $1.580 | $1.750 | $1.570 | 163,400 | |
| $1.540 | -0.550 | -26.3% | $2.100 | $2.100 | $1.450 | 403,700 | |
| $2.090 | +0.050 | +2.5% | $2.030 | $2.100 | $2.030 | 33,300 | |
| $2.040 | -0.070 | -3.3% | $2.150 | $2.300 | $1.880 | 102,400 | |
| $2.110 | -0.140 | -6.2% | $2.160 | $2.299 | $2.100 | 70,000 | |
| $2.250 | -0.190 | -7.8% | $2.490 | $2.490 | $2.132 | 112,300 | |
| $2.440 | -0.030 | -1.2% | $2.460 | $2.495 | $2.370 | 36,800 | |
| $2.470 | -0.170 | -6.4% | $2.600 | $2.700 | $2.460 | 66,100 | |
| $2.640 | +0.250 | +10.5% | $2.400 | $2.770 | $2.360 | 252,900 | |
| $2.390 | -0.080 | -3.2% | $2.500 | $2.690 | $2.360 | 87,300 | |
| $2.470 | -0.285 | -10.3% | $2.760 | $2.790 | $2.450 | 128,600 | |
| $2.755 | +0.025 | +0.9% | $2.740 | $2.827 | $2.582 | 120,800 | |
| $2.730 | -0.340 | -11.1% | $3.030 | $3.070 | $2.690 | 157,700 | |
| $3.070 | -0.020 | -0.6% | $3.100 | $3.241 | $3.040 | 90,800 | |
| $3.090 | -0.740 | -19.3% | $3.800 | $3.837 | $3.000 | 332,100 | |
| $3.830 | -0.220 | -5.4% | $4.000 | $4.100 | $3.810 | 49,800 | |
| $4.050 | -0.090 | -2.2% | $4.080 | $4.322 | $3.850 | 181,700 | |
| $4.140 | +0.260 | +6.7% | $3.850 | $4.280 | $3.810 | 276,900 | |
| $3.880 | +0.080 | +2.1% | $3.780 | $4.049 | $3.780 | 150,500 | |
| $3.800 | -0.180 | -4.5% | $3.920 | $4.050 | $3.760 | 84,000 | |
| $3.980 | -0.420 | -9.5% | $4.360 | $4.614 | $3.950 | 129,600 | |
| $4.400 | -0.340 | -7.2% | $5.200 | $5.247 | $4.400 | 237,500 | |
| $4.740 | +0.380 | +8.7% | $4.250 | $5.440 | $4.240 | 857,100 | |
| $4.360 | +0.280 | +6.9% | $4.180 | $4.500 | $4.060 | 119,600 | |
| $4.080 | +0.070 | +1.7% | $3.960 | $4.340 | $3.960 | 76,400 | |
| $4.010 | -0.200 | -4.8% | $4.150 | $4.350 | $3.900 | 114,700 | |
| $4.210 | -0.100 | -2.3% | $4.410 | $4.500 | $4.160 | 140,100 | |
| $4.310 | +0.135 | +3.2% | $4.230 | $4.450 | $4.170 | 143,000 | |
| $4.175 | -0.035 | -0.8% | $4.130 | $4.300 | $4.130 | 93,800 | |
| $4.210 | +0.210 | +5.2% | $4.050 | $4.300 | $4.040 | 117,700 | |
| $4.000 | +0.290 | +7.8% | $3.880 | $4.650 | $3.865 | 389,700 | |
| $3.710 | +0.100 | +2.8% | $3.630 | $3.850 | $3.590 | 87,500 | |
| $3.610 | +0.070 | +2.0% | $3.560 | $3.880 | $3.560 | 100,300 | |
| $3.540 | +0.040 | +1.1% | $3.500 | $3.620 | $3.420 | 60,700 | |
| $3.500 | -0.180 | -4.9% | $3.680 | $3.760 | $3.500 | 89,800 | |
| $3.680 | +0.150 | +4.2% | $3.500 | $4.050 | $3.500 | 196,400 | |
| $3.530 | -0.320 | -8.3% | $3.800 | $3.825 | $3.530 | 53,900 | |
| $3.850 | +0.190 | +5.2% | $3.660 | $3.910 | $3.660 | 64,500 | |
| $3.660 | -0.150 | -3.9% | $3.820 | $3.910 | $3.660 | 30,400 | |
| $3.810 | -0.110 | -2.8% | $3.870 | $3.990 | $3.750 | 62,700 | |
| $3.920 | +0.380 | +10.7% | $3.770 | $3.950 | $3.550 | 112,700 | |
| $3.540 | -0.140 | -3.8% | $3.690 | $3.800 | $3.500 | 63,400 | |
| $3.680 | +0.335 | +10.0% | $3.510 | $3.860 | $3.510 | 155,000 |
Splits
3 splits since 2008 · NASDAQ:BSEM · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-400 | Consolidation | |
| 1-for-35 | Consolidation | |
| 1-for-1000 | Consolidation |
- Ticker
- NASDAQ:BSEM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of Portfolio
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of Portfolio
Nov 12, 2026
Closed $1.05 (-19.2%) on Nov 13, 2026
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
Oct 29, 2026
Closed $1.12 (-13.2%) on Oct 30, 2026
BioStem Technologies, Inc. on 6ix
- News releases
- 2 in the last 12 months · 2 in all · newest Nov 12, 2026 · oldest 2026
- Decks
- 9 decks · latest September 2026
Valuation
balance Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $11.21M USD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.7×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.60
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 7.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -1.90 · 1 analyst
- Revenue, year to Dec 2026
- 28.74M · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Jason Matuszewski | Chief Executive Officer |
| Brandon Poe | Chief Financial Officer |
| Andrew Van Vurst | Chief Operating Officer |
| Katherine Gorrell | Chief Legal and Compliance Officer |
| Jeff Humke | Vice President of Human Resources |
| Lita Lilly | Vice President of Sales |
| Noah Agron | Vice President of Corporate Finance and Strategy |
| Vicky Oxley | Vice President of Marketing |
| Wendy W. Weston | Vice President of Research and Development |
| Barry Hassett | Chief Commercial Officer |
| Michael Fortunato | Chief Accounting Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 13, 2026 · After close | +3.5% |
| Quarter to Mar 31, 2026 | May 14, 2026 · After close | −14.2% |
| Q3 2025 | Nov 13, 2025 · After close | −4.0% |
| Q2 2025 | Aug 13, 2025 · After close | −2.8% |
| Quarter to Mar 31, 2025 | May 11, 2025 · After close | +0.6% |
| Quarter to Dec 31, 2024 | Mar 31, 2025 · Before open | −5.8% |
| Quarter to Sep 30, 2024 | Nov 11, 2024 · After close | +1.1% |
| Quarter to Jun 30, 2024 | Aug 12, 2024 · After close | +8.4% |
| Quarter to Mar 31, 2024 | May 14, 2024 · After close | +4.6% |
| Quarter to Dec 31, 2023 | Feb 28, 2024 | −1.4% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2023 | Nov 13, 2023 · After close | +4.8% |
| Quarter to Jun 30, 2023 | Aug 2, 2023 · After close | +8.3% |
| Quarter to Mar 31, 2023 | May 22, 2023 | |
| Quarter to Sep 30, 2022 | Nov 15, 2022 · After close | −33.3% |
| Quarter to Jun 30, 2022 | Aug 22, 2022 · After close | −3.3% |
| Quarter to Mar 31, 2022 | May 16, 2022 · After close | +60.8% |
| Quarter to Dec 31, 2021 | Mar 31, 2022 · After close | −5.6% |
| Quarter to Jun 30, 2021 | Aug 24, 2021 | +1.9% |
| Quarter to Mar 31, 2021 | Apr 6, 2021 | −1.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 21 slides | September 2026 |
| Q2 2026 Earnings Presentation | Earnings | 22 slides | August 2026 |
| Planet Microcap Conference Las Vegas 2026 | Conference | 17 slides | Jun 17, 2026 |
| Investor Presentation (April 2026) | Investor deck | 20 slides | April 2026 |
| Investor Presentation (March 2026) | Investor deck | 21 slides | March 2026 |
| Q4 2025 Earnings Presentation | Earnings | 20 slides | March 2026 |
| JP Morgan Healthcare Conference 2026 | Conference | 24 slides | January 2026 |
| Investor Presentation (March 2025) | Investor deck | 31 slides | March 2025 |
| Investor Presentation (October 2024) | Investor deck | 25 slides | October 2024 |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 424B3 · Prospectus | Nov 19, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Nov 19, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Nov 19, 2026 | Offer document | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 10, 2026 | Big-stake notice | SEC |
All 87 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 5, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| SEC STAFF LETTER | Oct 16, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Oct 13, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 9, 2026 | Insider trade | SEC |
| D | Oct 9, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 8, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Oct 8, 2026 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Oct 6, 2026 | Offer document | SEC |
| S-1 · Registration statement | Oct 2, 2026 | Offer document | SEC |
| 8-K · Current report | Sep 30, 2026 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Sep 30, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Sep 29, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | Sep 25, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 25, 2026 | Other filings | SEC |
| D | Sep 21, 2026 | Other filings | SEC |
| S-1 · Registration statement | Sep 18, 2026 | Offer document | SEC |
| 8-K · Current report | Sep 18, 2026 | Material contract | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2026 | Insider trade | SEC |
| 424B3 · Prospectus | Aug 14, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Aug 13, 2026 | Offer document | SEC |
| 8-K · Current report | Aug 12, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 12, 2026 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Aug 12, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 7, 2026 | Offer document | SEC |
| 8-K · Current report | Aug 7, 2026 | Current report | SEC |
| SEC STAFF ACTION | Aug 7, 2026 | Other filings | SEC |
| CERT · Exchange's certificate of listing | Aug 6, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 4, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 4, 2026 | Other filings | SEC |
| 10-12B/A | Aug 4, 2026 | Other filings | SEC |
| S-1 · Registration statement | Jul 29, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jul 24, 2026 | Other filings | SEC |
| 10-12B/A | Jul 24, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 22, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 9, 2026 | Other filings | SEC |
| 10-12G | Jul 9, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 15, 2026 | Other filings | SEC |
| D | Jun 3, 2026 | Other filings | SEC |
| DRSLTR · Letter to the SEC with a draft | May 28, 2026 | Other filings | SEC |
| DRS/A · Draft registration statement, amended | May 28, 2026 | Offer document | SEC |
| SEC STAFF LETTER | May 27, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 18, 2026 | Other filings | SEC |
| DRS · Draft registration statement | Apr 17, 2026 | Offer document | SEC |
| RW · Request to withdraw a registration | Oct 28, 2025 | Other filings | SEC |
| 10-12B/A | Jan 22, 2025 | Other filings | SEC |
| 10-12B/A | Nov 27, 2024 | Other filings | SEC |
| 10-12B | Sep 27, 2024 | Other filings | SEC |
| D | Apr 4, 2023 | Other filings | SEC |
| D | May 25, 2021 | Other filings | SEC |
| D | Aug 16, 2016 | Other filings | SEC |
| D | Feb 1, 2016 | Other filings | SEC |
Cap table
Built by 6ix from BioStem Technologies, Inc.’s releases · as of Nov 11, 2026
- Common shares
- 19,178,631
- Fully diluted
- 19,178,631
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 19,178,631 | Nov 11, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 11, 2026 | 19,178,631 |
| Sep 30, 2026 | 18,679,490 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark A. Glickman Other companies: MetaVia Inc. (Independent Director · Since at least May 11, 2023); TherapeuticsMD, Inc. (Co-Chief Executive Officer · Oct 15, 2021 – Dec 6, 2022 · Past); Esperion Therapeutics, Inc. (Chief Commercial Officer · Dec 20, 2018 – Jan 2, 2020 · Past); Aralez Pharmaceuticals Inc (Chief Commercial Officer · Feb 5, 2016 – Mar 19, 2018 · Past); POZEN Inc (Chief Commercial Officer · Jun 22, 2015 – Jun 22, 2015 · Past); Auxilium Pharmaceuticals Inc (EVP - Sales and Marketing · Feb 3, 2012 – Jan 29, 2015 · Past) | Director · Since at least Aug 6, 2026 |
| Andrew Van Vurst | Chief Operating Officer · Since at least Nov 5, 2026 |
| Barry Hassett | Chief Commercial Officer · Since at least Nov 3, 2026 |
| Brandon Poe | Chief Financial Officer · Since at least Aug 6, 2026 |
| Hannaway Rayna Lesser | Director · Since at least Aug 6, 2026 |
| Jason Matuszewski | Chief Executive Officer · Since at least Nov 5, 2026 |
| Jeff Humke | Vice President of Human Resources · Since at least Nov 4, 2026 |
| Jodi Ungrodt | Director · Since at least Aug 6, 2026 |
| Katherine Gorrell | Chief Legal and Compliance Officer · Since at least Nov 5, 2026 |
| Kenneth Howard Warrington Jr | Director · Since at least Aug 6, 2026 |
All 17 people
| Person | Seat |
|---|---|
| Lita Lilly | Vice President of Sales · Since at least Nov 5, 2026 |
| Michael Fortunato | Chief Accounting Officer · Since at least Aug 6, 2026 |
| Noah Agron | Vice President of Corporate Finance and Strategy · Since at least Nov 5, 2026 |
| Steven D Sonenreich | Director · Since at least Aug 6, 2026 |
| Vicky Oxley | Vice President of Marketing · Since at least Nov 4, 2026 |
| Vurst Andrew Smith-Van | Chief Operating Officer, Director · Since at least Aug 6, 2026 |
| Wendy W. Weston | Vice President of Research and Development · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about BioStem Technologies, Inc.